Page 21 - தொழிற்சங்கம் முதலீடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

4 Min Read FRANKFURT (Reuters) -Bayer shares dropped as much as 5% on Thursday after a U.S. judge rejected its plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer. The German group called into question the future sale of glyphosate-based products to gardeners in the U.S., and said it would review plans to settle around 30,000 legal claims, after the judge called Bayer’s plan to end years of litigation “unreasonable” on Wednesday. “We will continue to assess financial risks as we move forward,” finance chief Wolfgang Nickl said in an analyst call, when asked if the estimate of the potential financial burden had been revised.

San franciscoUnited statesMarkus mannsLudwig burgerVince chhabriaWilliam doderoWerner baumannBryan garnierWolfgang nicklEdwin hardemanUs environmental protection agencyThomson reuters trust principlesSupreme courtUs supreme courtUnion investmentBayer chief executive werner